Caregiver-led mobile tool to support healthy habits for kids treated for ALL
Official title: Adapting a caregiver-directed mHealth intervention to support positive health behaviors in children treated for Acute Lymphoblastic Leukemia
Funded at University of Minnesota · NIH-11630804 · Data updated 2026-11-12
A caregiver-directed mobile program helps children who were treated for acute lymphoblastic leukemia build healthier daily routines.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Minnesota NIH-funded |
| Lab location | 1 site (Minneapolis, United States) |
| Project start | September 18, 2026 |
| Project end | August 31, 2029 |
| Funding year | 2026 |
| Award (this year) | $18,229 |
| NIH project number | 3R34CA301428-01A1S1 |
| Project ID | NIH-11630804 on NIH RePORTER |
Who could benefit from this research
✓Could help
Children diagnosed with ALL (2-9 years at diagnosis) who are now survivors and at risk for cardiometabolic issues, with caregiver involvement.
✕Less likely to help
Families without access to a smartphone or those with barriers to sustained home-based behavioral changes may see limited benefit.
What this research studies
This project aims to adapt a caregiver-led mobile health approach to help families support healthy eating, activity, sleep, and reduced screen time for children who survived ALL. It focuses on home-based changes that parents can implement to improve long-term heart and metabolic health. The plan involves tailoring content to families’ routines, delivering simple activities through a smartphone platform, and integrating parenting strategies with the child’s unique medical history. The intervention seeks to be practical, scalable, and usable within real-world pediatric care settings.
Why it matters
Potential benefit: If successful, it could reduce future cardiometabolic risks for ALL survivors by promoting sustainable healthy behaviors.
How similar studies have gone: There is limited empirically supported, scalable caregiver-led mHealth work for ALL survivors, making this approach relatively novel.
Where this research is happening
-
University of Minnesota
Minneapolis, United States Active
Researchers
- Principal investigator: Kunin-Batson, Alicia S — University of Minnesota
- Study coordinator: Kunin-Batson, Alicia S
Related research
Other NIH-funded projects on the same topics.
-
Adapting a caregiver-led mobile program to boost healthy habits in kids treated for ALL
A caregiver-directed mobile health program helps children treated for acute lymphoblastic leukemia build healthy habits to reduce long-term heart and diabetes risk.
-
Genomics of childhood ALL across global populations
A wide-ranging study looks at how inherited genetics influence the risk of childhood acute lymphoblastic leukemia around the world.
-
Genomics of childhood ALL across diverse populations
A large international study will look at why children everywhere get acute lymphoblastic leukemia and how genetics may influence risk.
-
Combinatorial targeting for high-risk B-cell ALL treatment
A research effort at West Virginia University is exploring a combination therapy for adult B-cell acute lymphoblastic leukemia using targeted gene silencing and a small-molecule compound to improve treatment in patients.
-
Understanding why Latino children have a higher risk of childhood ALL
This project looks at why Latino children are more likely to develop acute lymphoblastic leukemia and whether genetic ancestry plays a role, with the goal of improving prevention and outcomes.
-
Targeting obesity to improve survival for children with ALL
A new approach explores whether reducing obesity-related factors can make chemotherapy work better for kids with acute lymphoblastic leukemia.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.